Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma.
The Discontinuation of Nucleos(t)ide Analogues Is Not Associated with A Higher Risk of HBsAg-Seroreversion after Antiviral-Induced HBsAg-Seroclearance: A Nationwide Multicentre Study
기타 URL :
https://www.ncbi.nlm.nih.gov/pubmed/32209606Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.
Pubmed URL :
https://www.ncbi.nlm.nih.gov/pubmed/30794889/Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
Pubmed URL :
https://www.ncbi.nlm.nih.gov/pubmed/28617992/Serum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort study.
Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for hepatocellular carcinoma patients beyond the Milan criteria.
Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting.
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.
Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study.
Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
A Phase I/IIa Study of Adjuvant Immunotherapy with Tumor Antigen-pulsed Dendritic Cells in Patients with Hepatocellular Carcinoma.
Myocardial Structural and Functional Changes in Patients with Liver Cirrhosis Awaiting Liver Transplantation ; A Comprehensive Cardiac Magnetic Resonance and Echocardiography Study
Evaluation of a Serum Tumor Marker-Based Recurrence Prediction Model after Radiofrequency Ablation for Hepatocellular Carcinoma.
Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study.
Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients.
Additional fibrate treatment in UDCA-refractory PBC patients.
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
Radiologic nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with suppressed chronic hepatitis B
Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study.
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study.
Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naive patients.
Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals
Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(t)ide Analogue-Experienced Chronic Hepatitis B Patients.
Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection.
Tenofovir Monotherapy versus Tenofovir plus Lamivudine or Telbivudine Combination Therapy in Treatment of Lamivudine-Resistant Chronic Hepatitis B.
Hepatitis B virus-related glomerulonephritis: not a predominant cause of proteinuria in korean patients with chronic hepatitis B.
CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.
Efficacy of Entecavir plus Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multi-Drug Resistant Strains.
Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.
Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?
Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet.
Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.
High-sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis.
Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis.
Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence
Prior exposure to lamivudine increases entecavir-resistance risk in chronic hepatitis B patients without detectable lamivudine-resistance.
Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization.
Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis.
Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.
Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection.
Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.
High-sensitivity C-reactive Protein Level is an Independent Predictor of Poor Prognosis in Cirrhotic Patients With Spontaneous Bacterial Peritonitis.
Excellent outcome in 238 consecutive living donor liver transplantations using the right liver graft in a large volume single center.
Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Transarterial chemoembolization with additional Cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Simple Scoring System Predicting Genotypic Resistance During Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition
Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.
Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis.
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation
Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
Mesalamine-induced B7-H1 expression on hepatic stellate cells attenuates autoimmune liver injury.
Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma.
Hepatic steatosis index: A Simple screening tool reflecting nonalcoholic fatty liver disease.
High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.
Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients.
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis
Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth.
Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Wnt signaling enhances the activation and survival of human hepatic stellate cells
Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients